ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 100071 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 100071; 2) Community: the network communities that were significantly associated with the response to NSC 100071; 3) Molecule: the relationships between components within communities and NSC 100071; 4) MDR: the compounds that were significantly associated with the NSC 100071.

NSC Compound Enrichment Correlation
NSC 733154 Null 0.0102077332082017 0.25269952
NSC 746058 Null 0.0102077332082017 0.30413062
NSC 748148 5-iodo-2-{[(2)-3-(2-chlorophenyl)prop-2-enoyl]amino}benzamide 0.0102077332082017 0.21319761
NSC 293046 Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide 0.0102962192514438 0.47762028
NSC 352741 Null 0.0102962192514438 0.31593727
NSC 617826 Null 0.0102962192514438 0.51758157
NSC 637693 Ethanedioic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d]thiazol-2-yl)hydrazide, monoethyl ester 0.0102962192514438 0.23915647
NSC 639503 Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride 0.0102962192514438 0.51646982
NSC 643813 3'-O-(Carboxymethyl)-(Z)-Combretastatin 4-A, Na salt, hydrate [1:1:2] 0.0102962192514438 0.076071402
NSC 658142 2-(1-(4-(2-Pyridyl)piperazino))naphthazarin 0.0102962192514438 0.44763343
Total:78  Current:14    [First] [Prev] [Next] [Last]